Drug Discov Ther. 2015;9(3):156-164. (DOI: 10.5582/ddt.2015.01012)
Multidrug resistant tuberculosis treatment in India.
Prasad R, Gupta N, Balasubramanian V, Singh A
Multidrug-resistant tuberculosis (MDR-TB) is posing a major public health threat as well as a big challenge to global efforts of tuberculosis control. The management of MDRTB patients is difficult, expensive, challenging and quite often leads to treatment failure. To avoid further transmission, a comprehensive approach for rapid detection, proper treatment and effective public health measures must be ensured. It must also be emphasized that even optimal treatment of MDR-TB will not alone curb the epidemic. Efforts must be focused on the effective use of first-line drugs in every new case so as to prevent the ultimate emergence of MDR-TB.